Finance
Results: 18517-18528 of 40903

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance

Multiply Group Signs Landmark Investment with CVC and PAI Partners to Secure a Controlling Stake (67.91%) in Tendam, with the Transaction Expected to Double Multiply’s Operational EBITDA Post-Consolidation

Hundreds of tissue regeneration medical devices seized for alleged patent infringement and potential health risks








